5U. S. Food and Drug Administration. Drug Safety and Availability. Informtion for healthcare professiona/s: desmopressin acetate ( marketed as DDAVP nasal spray, DDAVP rhinal tube, DDAVP, DDVP, Minirin, and Stimate nasal spray) [ EB/OL]. (2007-12- 04) [ 2013-10-01]. http://www, fda. gov/Drugs/DrugSafety/ PostmarketDrugSafetylnformationforPatientsandProviders/uem1255 61. him.
6Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP) [J]. J Thromb Haemost, 2003, 1(4) : 682-689.
7Schwartz WB, Bennett W, Curelop S, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiurctic hormone. 1957 [ J]. J Am Soc Nephrol, 2001, 12 ( 12 ) : 2860-2870.
